- Home
- CNTA vs KFY Comparison
CNTA vs KFY Comparison
Compare CNTA & KFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTA | KFY |
|---|---|---|
| Founded | 2020 | 1969 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.4B |
| IPO Year | 2021 | 1998 |
Fundamental Metrics
Financial Performance| Metric | CNTA | KFY |
|---|---|---|
| Price | $39.85 | $62.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $42.50 | ★ $71.33 |
| AVG Volume (30 Days) | ★ 3.2M | 518.1K |
| Earning Date | 05-13-2026 | 03-09-2026 |
| Dividend Yield | N/A | ★ 3.05% |
| EPS Growth | 29.13 | ★ 42.41 |
| EPS | N/A | ★ 3.84 |
| Revenue | $15,000,000.00 | ★ $1,819,519,000.00 |
| Revenue This Year | N/A | $7.14 |
| Revenue Next Year | N/A | $3.32 |
| P/E Ratio | ★ N/A | $16.39 |
| Revenue Growth | N/A | ★ 12.20 |
| 52 Week Low | $9.60 | $58.27 |
| 52 Week High | $40.26 | $78.50 |
Technical Indicators
Market Signals| Indicator | CNTA | KFY |
|---|---|---|
| Relative Strength Index (RSI) | 78.06 | 49.40 |
| Support Level | $22.49 | $62.46 |
| Resistance Level | N/A | $64.35 |
| Average True Range (ATR) | 1.66 | 1.62 |
| MACD | 1.11 | 0.25 |
| Stochastic Oscillator | 97.05 | 64.93 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About KFY Korn Ferry
Korn Ferry is a consulting firm that powers performance. The Company helps unlock the potential in people and unleash transformation across organizations synchronizing, operations, and talent to accelerate performance, fuel growth, and inspire a legacy of change. The company's segment includes Consulting, Digital, Executive Search North America, Executive Search EMEA, Executive Search APAC, Executive Search Latin America, Professional Search & Interim and RPO. The company generates the majority of its revenue from the Executive Search segment and Consulting segment. The Executive search segment helps organizations recruit board-level, chief executive, and other C-suite/senior executive and general management talent to deliver lasting impact.